Brought to you by 
Merck and Piramal work on cancer targets
02 Jan 2008
Executive Summary
Merck & Co.'s Merck Sharp & Dohme division in India has agreed to work with Nicholas Piramal to discover and develop new cancer drugs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com